What medications are typically prescribed post-delivery?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 11, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Post-Delivery Medication Management

Post-delivery pain management should prioritize scheduled non-opioid analgesics (acetaminophen and NSAIDs) as first-line therapy, with opioids reserved only for severe breakthrough pain that interferes with recovery, breastfeeding, or infant care. 1

Pain Management After Vaginal Delivery

First-Line Approach (Opioid-Naïve Women)

Non-pharmacologic interventions:

  • Ice packs, heating pads, hydrocortisone, and local anesthetic application to the perineum 1

Scheduled medications:

  • Acetaminophen: 975 mg every 8 hours OR 650 mg every 6 hours by mouth 1
  • Ibuprofen: 600 mg every 6 hours by mouth 1

Second-Line Options

If pain inadequately controlled with acetaminophen and ibuprofen:

  • Ketorolac: 15-30 mg IV/IM every 6 hours for maximum 48 hours (if oral NSAIDs not tolerated) 1
  • Epidural morphine or hydromorphone: Consider only for significant laceration repairs before catheter removal (requires 24-hour respiratory monitoring) 1

Rescue Therapy

Only for severe pain uncontrolled by above measures:

  • Short course of low-dose opioids: 5-10 tablets of hydrocodone 5 mg 1
  • Critical caveat: Severe pain after vaginal delivery is unusual and should prompt evaluation for unrecognized complications (hematoma, infection, undiagnosed laceration) 1

Pain Management After Cesarean Delivery

Intraoperative/Immediate Postoperative

Neuraxial opioids (most effective):

  • Intrathecal morphine: 50-100 mcg OR diamorphine 300 mcg administered pre-operatively 1
  • Epidural morphine: 2-3 mg OR diamorphine 2-3 mg (if combined spinal-epidural technique used) 1

Scheduled Postoperative Regimen

Standing orders for first 48 hours:

  • Acetaminophen: 975 mg by mouth every 8 hours (scheduled, not as-needed) 1, 2
  • Ketorolac: 30 mg IV every 6 hours for 24 hours, then switch to 1
  • Ibuprofen: 600 mg by mouth every 6 hours 1

Evidence strongly supports scheduled dosing: Scheduled administration of acetaminophen and ibuprofen reduces opioid consumption by 64% and significantly improves pain scores compared to as-needed dosing 2

Rescue Opioid Therapy

Only if pain interferes with mobilization, breastfeeding, or infant care despite scheduled non-opioids:

  • Oxycodone: Maximum 30 mg daily (six 5-mg tablets) as needed 1
  • Critical discharge guideline: If women are NOT taking opioids in the hospital, do NOT prescribe at discharge 1
  • If opioids needed at discharge: Use shared decision-making to prescribe no more than equivalent of twenty 5-mg oxycodone tablets 1

Alternative Approaches If Neuraxial Opioids Not Used

Consider these interventions:

  • Single-injection local anesthetic wound infiltration 1
  • Continuous wound local anesthetic infusion 1
  • Fascial plane blocks (transversus abdominis plane or quadratus lumborum blocks) 1

Special Populations

Women with Preeclampsia with Severe Features

NSAIDs are safe and do NOT prolong severe-range hypertension:

  • Ibuprofen 600 mg every 6 hours does not lengthen duration of severe-range hypertension compared to acetaminophen 3
  • Exception: Avoid NSAIDs if acute kidney injury present (serum creatinine >1.0 mg/dL) 3

Opioid-Dependent Women

During labor and vaginal delivery:

  • Continue daily maintenance medication (methadone or buprenorphine) throughout labor to prevent withdrawal 1
  • Encourage early neuraxial analgesia (epidural or combined spinal-epidural) 1
  • Avoid: Opioid agonist-antagonists (nalbuphine, butorphanol) as they precipitate withdrawal 1

Postpartum pain management:

  • Multimodal approach with scheduled non-opioids as baseline 1
  • Additional systemic opioids may be necessary but should not be routine 1
  • For women on buprenorphine: Use full opioid agonists with strong mu-receptor affinity (fentanyl or hydromorphone) if additional analgesia needed 1

Additional Postpartum Medications (Non-Analgesic)

Uterotonic Agents

For prevention/control of postpartum hemorrhage:

  • Oxytocin: 10-40 units added to 1000 mL non-hydrating diluent, infused at rate necessary to control uterine atony 4
  • Intramuscular oxytocin: 10 units after placenta delivery 4

Antiemetic Prophylaxis

Multimodal approach recommended:

  • 5-HT3 antagonists (ondansetron, granisetron) for intraoperative and postoperative nausea/vomiting 1
  • Dexamethasone: Single IV dose after delivery (reduces nausea and improves analgesia) 1
  • Combination regimens (5-HT3 plus droperidol or dexamethasone) more effective than single agents 1

Critical Opioid Safety Considerations

Risk of persistent opioid use:

  • Approximately 1 in 300 opioid-naïve women exposed to opioids after cesarean delivery develop chronic use within one year 1
  • Risk factors include: younger age, smoking, other substance use, chronic pain conditions, antidepressant or benzodiazepine use 1

Leftover medication hazards:

  • Median opioid tablets dispensed after cesarean: 40; median consumed: 20 1
  • 95% of women with unused medication do not dispose of it, creating diversion and accidental exposure risks 1

Opioid side effects to monitor:

  • Nausea, dizziness, lethargy, constipation, respiratory depression 1

Common Pitfalls to Avoid

  • Over-prescribing opioids at discharge: Most women do not need opioids after vaginal delivery; limit to ≤20 tablets after cesarean if needed 1
  • As-needed dosing of non-opioids: Scheduled acetaminophen and NSAIDs provide superior pain control and reduce opioid consumption 2, 5
  • Dismissing severe pain as normal: Unusual severe pain warrants evaluation for complications 1
  • Using opioid agonist-antagonists in opioid-dependent women: These precipitate withdrawal 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.